NHPBSC Uses, Dosage, Side Effects and more
Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.
| Trade Name | NHPBSC |
| Generic | Autologous Non-Hematopoietic Peripheral Blood Stem Cells |
| Autologous Non-Hematopoietic Peripheral Blood Stem Cells Other Names | NHPBSC, UAECell19 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
